Alex Blatt

TL;DR: High-dose isosorbide dinitrate, given as repeated intravenous boluses after low-dose intravenous furosemide, is safe and effective in controlling severe pulmonary oedema.

TL;DR: High dose ISDN is safer and better than BiPAP ventilation combined with conventional therapy in patients with severe pulmonary edema, and the study was prematurely terminated by the safety committee.

TL;DR: Treatment of cardiogenic shock should be directed at improving cardiac performance, by optimizing filling pressure, intra‐aortic balloon pump and immediate revascularization and administration of peripheral vasoconstrictors, along with efforts to optimize cardiac function.

TL;DR: Nonadherence to medications predicts adverse outcome during the first year after an acute MI and is associated with PTSD symptoms, which may either be a marker for or a cause of nonadherence.

TL;DR: The results of the present study further support the previous observation that NO synthase inhibitors are beneficial in the treatment of patients with refractory cardiogenic shock.